These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1558519)

  • 21. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease.
    Kaufer DI; Miller BL; Itti L; Fairbanks LA; Li J; Fishman J; Kushi J; Cummings JL
    Neurology; 1997 Apr; 48(4):978-85. PubMed ID: 9109887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinico-tomographic correlates in Alzheimer's disease].
    Selezneva ND; Kolykhanov IV; Nikiforuk NM; Savvateva NIu; Ermilova EN; Vavilov SB; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):65-9. PubMed ID: 8009938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease.
    Zhang Y; Londos E; Minthon L; Wattmo C; Liu H; Aspelin P; Wahlund LO
    Acta Radiol; 2008 Feb; 49(1):91-7. PubMed ID: 18210318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alzheimer's syndrome--the history of a disease and the role of modern diagnostic radiology].
    Essig M; Reith W
    Radiologe; 2003 Jul; 43(7):511-2. PubMed ID: 12962082
    [No Abstract]   [Full Text] [Related]  

  • 25. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data.
    Charpentier P; Lavenu I; Defebvre L; Duhamel A; Lecouffe P; Pasquier F; Steinling M
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):661-3. PubMed ID: 11032624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
    Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O;
    Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images.
    Freeborough PA; Fox NC
    J Comput Assist Tomogr; 1998; 22(5):838-43. PubMed ID: 9754126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alzheimer's disease].
    Groppa SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):105-12. PubMed ID: 2176026
    [No Abstract]   [Full Text] [Related]  

  • 30. MR image texture analysis applied to the diagnosis and tracking of Alzheimer's disease.
    Freeborough PA; Fox NC
    IEEE Trans Med Imaging; 1998 Jun; 17(3):475-9. PubMed ID: 9735911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Diagnostic Accuracy of Alzheimer's Disease by Combining Regional Cortical Thickness and Default Mode Network Functional Connectivity: Validated in the Alzheimer's Disease Neuroimaging Initiative Set.
    Park JE; Park B; Kim SJ; Kim HS; Choi CG; Jung SC; Oh JY; Lee JH; Roh JH; Shim WH;
    Korean J Radiol; 2017; 18(6):983-991. PubMed ID: 29089831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of multidimensional scaling to quantify shape in Alzheimer's disease and its correlation with Mini Mental State Examination: a feasibility study.
    Park H; Seo J;
    J Neurosci Methods; 2011 Jan; 194(2):380-5. PubMed ID: 21074558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early diagnosis of Alzheimer's disease.
    Small G
    New Dir Ment Health Serv; 1997; (76):39-51. PubMed ID: 9520524
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography.
    Dahmus MA; Barton JR; Sibai BM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):935-41. PubMed ID: 1415428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease and acetylcholinesterase inhibitor agents: a two-year longitudinal study.
    Fuschillo C; Ascoli E; Franzese G; Campana F; Cello C; Galdi M; La Pia S; Cetrangolo C
    Arch Gerontol Geriatr Suppl; 2004; (9):187-94. PubMed ID: 15207413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease.
    Glodzik-Sobanska L; Rusinek H; Mosconi L; Li Y; Zhan J; de Santi S; Convit A; Rich K; Brys M; de Leon MJ
    Neuroimaging Clin N Am; 2005 Nov; 15(4):803-26, x. PubMed ID: 16443492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR and PET vie in diagnosis of Alzheimer's disease.
    Lowers J
    Diagn Imaging (San Franc); 2000 Nov; 22(11):113-6. PubMed ID: 11148954
    [No Abstract]   [Full Text] [Related]  

  • 38. Brain imaging in Alzheimer's disease.
    McGeer PL
    Br Med Bull; 1986 Jan; 42(1):24-8. PubMed ID: 3513888
    [No Abstract]   [Full Text] [Related]  

  • 39. Discriminative analysis of early Alzheimer's disease using multi-modal imaging and multi-level characterization with multi-classifier (M3).
    Dai Z; Yan C; Wang Z; Wang J; Xia M; Li K; He Y
    Neuroimage; 2012 Feb; 59(3):2187-95. PubMed ID: 22008370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography and magnetic resonance imaging in adult-onset leukodystrophy.
    Schwankhaus JD; Patronas N; Dorwart R; Eldridge R; Schlesinger S; McFarland H
    Arch Neurol; 1988 Sep; 45(9):1004-8. PubMed ID: 3415518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.